Slow growth expected for worldwide nuclear imaging market

The global market for nuclear imaging technology is forecasted to reach $2.2 billion in 2020, just a 3.3 percent compound annual growth rate over the $1.83 billion noted for 2013, according to a December 2014 report by GlobalData.

The data shows the U.S. being hit the hardest due to strained reimbursement. In contrast, China could yield as much as 100 percent growth in market shares by 2020 and Japan as much as 75 percent growth. PET/CT and PET/MR procedures are on the rise with more indications and other modalities may see a slump in procedure numbers in PET’s wake.

Market analysts report that “explosive growth” in global PET/CT has had an adverse impact on healthcare budgets. PET/CT has now all but replaced PET only systems and SPECT systems remain the workhorse in cardiovascular imaging.

The markets for SPECT and SPECT/CT are significantly larger than for PET due to price difference and familiarity with the technology. However, PET is expected to continue its takeover into traditionally SPECT dominated areas of imaging.

 

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.